One2Treat
Board
3 directors, 3 in day-to-day management, no change since 2025Chair, director and managing director, permanent representative
appointed by deed of 17-07-2023
also on the board of 2 other companies
Director, permanent representative
since 06-07-2023
term until 17-05-2030
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 16-06-2026
Director and daily management delegate, permanent representative
director appointed by deed of 23-12-2024
daily management delegate appointed by deed of 09-01-2025
- , ,
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- The sole directordeed of 09-01-2025
Permanent representatives 3
Mandates through the years
4 names, the dashed line is todayDirector
Director, Chair, Managing director
Director, Daily management delegate
Managing director
LeadershipBoardRest of the term
Mandates as a list
-
- Director, from 06-07-2023 to date
-
- Director, from 06-07-2023 to date
- Chair, appointed by deed of 17-07-2023, still in office
- Managing director, appointed by deed of 17-07-2023, still in office
-
- Director, from 30-01-2024 to date
- Daily management delegate, appointed by deed of 09-01-2025, still in office
-
- Managing director, appointed by deed of 28-05-2024, still in office
With Starter you also see 3 former office holders in the mandate history.
See plans →
Control
Parent
Equity €14.8m
Profit €48.3m in 2025 (loss €131,840 in 2024)
54.78%
This company
One2Treat
Equity €622,824
Loss €1.1m in 2025
Further up the chain 50.69%
Capital
- Capital
- €2,800,000
- Shares
- 420,000 in the deed of 17-07-2023 and 2 later capital increases
- Contribution per share
- €6.67
- Equity per share
- €1.48 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
-
- 2023: 28.38%
- 2024 to 2025: 27.4%
-
- 2023: 62.86%
- 2024: 54.78%
Source: lists of holdings in the owners' accounts
Articles of association
deed of 09-01-2025 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Term of at most 6 years
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of May at 11:00
Shareholders
2 ownersOwners 2
- parentEquity €14.8m Profit of €48.3m in 2025 (loss of €131,840 in 2024)Sourceaccounts 202554.78%
- Equity €192.5m Profit of €24.4m in 2025 (profit of €165.3m in 2024) Checked scoreSourceaccounts 202527.4%
Capital transactions
Shareholders according to the deeds
After 3 capital increases
deed of 09-01-2025 ↗
- 57,900 shares · “actions nouvelles”
- 44,000 shares · “actions nouvelles”
- 21,000 shares · “actions nouvelles”
- 1,200 shares · “actions nouvelles”
- 1,000 shares · “actions nouvelles”
- 500 shares · “actions nouvelles”
- 7,000 shares · “actions nouvelles”
- 1,000 shares · “actions nouvelles”
- 1,000 shares · “actions nouvelles”
- 1,000 shares · “actions nouvelles”
- 1,000 shares · “actions nouvelles”
- 700 shares · “actions nouvelles”
- 300 shares · “actions nouvelles”
- 1,000 shares
- 500 shares
- 200 shares
- 1,000 shares
At incorporation
deed of 17-07-2023 ↗
- founder
- founder
Capital over time
- 09-01-2025 Capital increase of €1,400,000 · 140,000 new shares at €10 per share · in cash
- 09-01-2025 Capital increase of €1,400,000 · 140,000 new shares
- 17-07-2023 Incorporation · €1,400,000 · 140,000 shares